Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
S&P 500 Hits Another New All-Time High

The index's totals weren't super-noteworthy in the daily performance, +0.33%, but this April has seen multiple new highs four of the past six sessions.

JNJ : 159.48 (-1.34%)
AZN : 49.19 (-0.47%)
AAPL : 134.43 (+2.43%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
Sage (SAGE), Biogen Report Positive Data on Essential Tremor Study

Sage (SAGE) and partner Biogen (BIIB) announce positive top-line results from the phase II, placebo-controlled KINETIC study in patients with essential tremor.

BIIB : 266.19 (+1.29%)
MRNA : 149.71 (+7.40%)
RGEN : 212.86 (+2.82%)
SAGE : 71.94 (-3.67%)
Myovant (MYOV), Pfizer Start Dosing in Relugolix Combo Study

Myovant (MYOV) and Pfizer (PFE) initiate dosing in the phase III SERENE study evaluating the contraceptive efficacy of the relugolix combination tablet.

PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
RGEN : 212.86 (+2.82%)
MYOV : 17.07 (-0.64%)
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day

--Antibody persistence data out to 6 months published in The New England Journal of Medicine

MRNA : 149.71 (+7.40%)
Consumer Price Index Rise 0.6%

Consumer Price Index Rise 0.6%

JNJ : 159.48 (-1.34%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
BNTX : 129.64 (+6.68%)
CPI +0.6%: Higher, but Not Scary; JNJ Vax on Hold?

Headline CPI last month reached +0.6%, 10 basis points ahead of consensus, and the highest single-month tally since June of 2009.

JNJ : 159.48 (-1.34%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
BNTX : 129.64 (+6.68%)
Thinking about trading options or stock in Moderna, BioNTech, AstraZeneca, Overstock.com, or GrubHub?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA, BNTX, AZN, OSTK, and GRUB.

AZN : 49.19 (-0.47%)
BNTX : 129.64 (+6.68%)
MRNA : 149.71 (+7.40%)
OSTK : 77.75 (+7.55%)
GRUB : 72.00 (+7.61%)
Bristol Myers' (BMY) Opdivo Combo Encouraging in NSCLC study

Bristol Myers Squibb (BMY) announces positive results from a late-stage study evaluating Opdivo plus chemotherapy for resectable NSCLC.

RHHBY : 41.6900 (+0.29%)
MRK : 76.43 (+0.28%)
MRNA : 149.71 (+7.40%)
BMY : 63.58 (+1.42%)
Has Moderna (MRNA) Outpaced Other Medical Stocks This Year?

Is (MRNA) Outperforming Other Medical Stocks This Year?

MRNA : 149.71 (+7.40%)
Stock Market News for Apr 12, 2021

Benchmarks hit record levels on Friday, closing in the green for consecutive weeks as investors shrugged off inflation fears and focused on quarterly earnings season amid reopening optimism

UNH : 374.50 (-0.47%)
AMZN : 3,400.00 (+0.61%)
AAPL : 134.43 (+2.43%)
PFE : 37.16 (+0.51%)
HON : 229.00 (+0.17%)
MRNA : 149.71 (+7.40%)
CRM : 232.00 (+1.42%)
ALGN : 595.63 (-0.91%)
CPRT : 117.53 (-0.66%)
GOOGL : 2,254.43 (+0.44%)
OKTA : 265.32 (+6.57%)
J&J's (JNJ) COVID-19 Jab Under EU Review for Rare Blood Clots

The European drug regulator's safety committee is conducting a review to asses a link between J&J's (JNJ) COVID-19 vaccine and rare blood clots.

JNJ : 159.48 (-1.34%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
BNTX : 129.64 (+6.68%)
Bristol Myers' (BMY) Opdivo Combo Positive in ESCC Study

Bristol Myers (BMY) announces encouraging data from the late-stage study evaluating Opdivo plus chemotherapy and Opdivo plus Yervoy in ESCC study.

RHHBY : 41.6900 (+0.29%)
MRK : 76.43 (+0.28%)
MRNA : 149.71 (+7.40%)
BMY : 63.58 (+1.42%)
ImmunityBio (IBRX) Reports Positive COVID-19 Vaccine Data

ImmunityBio (IBRX) reports positive initial data on its COVID-19 vaccine candidate in healthy phase I study participants.

JNJ : 159.48 (-1.34%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
IBRX : 16.76 (+4.16%)
Merck (MRK) Keytruda Meets Endpoint in Kidney Cancer Study

Merck (MRK) is developing a Keytruda monotherapy regimen for adjuvant treatment of renal cell carcinoma patients.

PFE : 37.16 (+0.51%)
MRK : 76.43 (+0.28%)
MRNA : 149.71 (+7.40%)
RGEN : 212.86 (+2.82%)
Higher-Than-Expected PPI in March

Higher-Than-Expected PPI in March.

PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
PPI Doubles Month Over Month to 1.0%

We haven't seen a higher headline PPI figure since the fallout of the pandemic era, now more than a year ago.

PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
Lilly's (LLY) JAK Inhibitor Olumiant Fails COVID-19 Study

Lilly (LLY) and Incyte's Olumiant (baricitinib) in combination standard of care fails in a late-stage study evaluating it in hospitalized COVID-19 patients.

GILD : 64.89 (+0.36%)
INCY : 80.65 (+0.98%)
MRNA : 149.71 (+7.40%)
LLY : 182.53 (+0.39%)
Moderna to Present at the 20th Annual Needham Virtual Healthcare Conference

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that David Meline, Chief Financial Officer, and Lavina Talukdar, Senior...

MRNA : 149.71 (+7.40%)
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

AZN : 49.19 (-0.47%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
NVAX : 194.66 (+10.82%)
IBB : 149.21 (+1.85%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
FBT : 158.92 (+0.79%)
BTEC : 57.07 (+1.75%)
BNTX : 129.64 (+6.68%)
AstraZeneca (AZN) COVID-19 Jab May Have Link to Rare Blood Clots

European regulators find a possible link between AstraZeneca's (AZN) COVID-19 vaccine and rare blood clot events.

AZN : 49.19 (-0.47%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
BNTX : 129.64 (+6.68%)

Barchart Exclusives

Lumber Continues To Send A Signal To Markets
Lumber moved above the $1200 per 1,000 board feet level this week. The volatile wood price continues to rise to unprecedented territory. Lumber is sending a signal to markets across all asset classes. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar